Results 31 to 40 of about 6,750 (143)

Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis Syndrome with Purely Osteolytic, Not Osteosclerotic, Lesions Mimicking a Malignant Tumor

open access: yesCase Reports in Rheumatology, 2020
Synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome is a rare inflammatory disorder with multiple phenotypes. The syndrome has identifiable radiologic characteristics that are the most important when making a diagnosis.
Hideyuki Kinoshita   +9 more
doaj   +1 more source

Three Cases of Palmoplantar Pustulosis Caused by Dental Metal [PDF]

open access: yes, 2004
Palmoplantar pustulosis is a stubborn disease with repeated aseptic small pustulations on the palms and soles of the feet. Chronic tonsillitis and chronic odontogenic infectious lesions are suspected as one of the causes of the disease.Recently it has ...
栗田, 浩   +4 more
core   +1 more source

Possible Efficacy of Vedolizumab, an Anti-α4β7 Integrin Antibody, in Palmoplantar Pustulosis

open access: yesCase Reports in Dermatology, 2023
Palmoplantar pustulosis (PPP) is a chronic skin inflammatory disease in which blisters and pustules repeatedly develop on palms and soles. PPP is often refractory to topical therapy, oral therapy, phototherapy, and biologics that are usually applied for ...
Hitoshi Terui   +4 more
doaj   +1 more source

Somatostatin receptors are strongly expresssed in palmoplantar sweat glands and ducts: studies of normal and palmoplantar pustulosis skin

open access: yes, 2011
Summary Background. The acrosyringium is the target for inflammation in the chronic and intensely inflammatory skin disease palmoplantar pustulosis (PPP).
E. Hagforsen   +5 more
core   +1 more source

Apremilast in Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic Review and Meta-analysis [PDF]

open access: yes, 2023
BACKGROUND: This review’s goals were to investigate apremilast’s efficacy versus placebo in palmoplantar psoriasis (PP) and palmoplantar pustulosis (PPP), and apremilast’s efficacy versus methotrexate in PP.
Spencer, Riley K.   +10 more
core   +1 more source

The histopathological spectrum of acute generalized exanthematous pustulosis (AGEP) and its differentiation from generalized pustular psoriasis [PDF]

open access: yes, 2010
Background: Acute generalized exanthematous pustulosis (AGEP) represents a severe, acute, pustular skin reaction that is most often induced by drugs. AGEP can be difficult to differentiate from generalized pustular psoriasis (GPP) both clinically and ...
Fidler, Vaclav   +11 more
core   +2 more sources

Transient hypercalcemia in a patient with SAPHO syndrome

open access: yesJournal of General and Family Medicine, 2022
We here report a case of SAPHO (synovitis‐acne‐pustulosis‐hyperostosis‐osteitis) syndrome with hypercalcemia. The patient was diagnosed with SAPHO syndrome at the age of 54, because he exhibited osteitis and hyperostosis around the sternoclavicular ...
Tadashi Yoshida, Mototsugu Oya
doaj   +1 more source

Paradoxical Alopecia Areata Induced by IL‐17 and IL‐23 Inhibitors: A Systematic Review

open access: yesJEADV Clinical Practice, EarlyView.
This systematic review identifies consistent clinical patterns of alopecia areata associated with IL‐17 and IL‐23 inhibitors, most frequently involving secukinumab and ustekinumab. Disease severity varied widely, and management often required biologic discontinuation or therapeutic switching.
Isabella Kamholtz   +2 more
wiley   +1 more source

Successful Treatment of a Patient with Pyoderma Gangrenosum, Plaque Psoriasis and Palmoplantar Pustulosis with Adalimumab

open access: yesClinical, Cosmetic and Investigational Dermatology, 2022
Yuqi Chu, Taoming Liu, Juan Bai, Hong Fang, Jianjun Qiao Department of Dermatology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People’s Republic of ChinaCorrespondence: Jianjun Qiao, Department of Dermatology, The ...
Chu Y, Liu T, Bai J, Fang H, Qiao J
doaj  

Exploratory MRI and Clinical Marker Analysis of Pustulotic Arthro‐Osteitis Disease Activity From a Phase 3 Brodalumab Trial

open access: yesThe Journal of Dermatology, EarlyView.
ABSTRACT Pustulotic arthro‐osteitis (PAO) is a clinically important osteoarticular comorbidity affecting approximately 9%–28% of patients with palmoplantar pustulosis (PPP), yet early recognition and standardized activity assessment remain challenging, particularly in routine dermatology practice.
Taiki Nozaki   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy